02.06.2013 Views

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

210 ESCITALOPRAM<br />

Cough (1–10%)<br />

Hot flashes (1–10%)<br />

Inappropriate secretion of antidiuretic hormone (SIADH)<br />

(2006): Adiga GU+, Clin <strong>Drug</strong> Investig 26(10), 607<br />

(2006): Nirmalani A+, CNS Spectr 11(6), 429<br />

(2004): Nahshoni E+, J Clin Psychiatry 65(12), 1722<br />

Lipomatosis<br />

Myalgia/Myositis/Myopathy/Myotoxicity (1–10%)<br />

Thrombosis<br />

(2004): Kurne A+, Gen Hosp Psychiatry 26(6), 481<br />

Upper respiratory infection<br />

(2005): Bielski RJ+, Ann Clin Psychiatry 17(2), 65<br />

ESMOLOL<br />

Trade name: Brevibloc (Baxter)<br />

Indications: Tachyarrhythmias, tachycardia<br />

Category: Adrenergic beta-receptor antagonist; Antiarrhythmic<br />

class II<br />

Half-life: 9 minutes<br />

Clinically important, potentially hazardous interactions<br />

with: clonidine, verapamil<br />

Reactions<br />

Skin<br />

Acne (10%)<br />

Eczema (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!